Vera Therapeutics, Inc.
VERA
36 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 17 8:28 PM | Marshall FordyceDirector, PRESIDENT AND CEO | Sale | 18,500 | $37.00 | $684.5K | 235,244(D) | View → |
| Sep 2, 2026 | Sep 4 8:15 PM | Marshall FordyceDirector, PRESIDENT AND CEO | Sale | 18,500 | $35.12 | $649.6K | 235,244(D) | View → |
| Sep 2, 2026 | Sep 2 8:32 PM | MARSHALL FORDYCE | Proposed Sale | 64,750 | $34.23 | $2.2M | — | View → |
| Jul 7, 2026 | Aug 12 10:42 PM | Marshall FordyceDirector, PRESIDENT AND CEO | Sale | 46,250 | $42.30 | $2.0M | 235,244(D) | View → |
| Jun 23, 2026 | Aug 12 10:41 PM | Marshall FordyceDirector, PRESIDENT AND CEO | Sale | 18,500 | $37.93 | $701.8K | 235,244(D) | View → |
| May 12, 2026 | Aug 12 10:39 PM | Marshall FordyceDirector, PRESIDENT AND CEO | Sale | 18,500 | $36.74 | $679.7K | 235,244(D) | View → |
| Jul 7, 2026 | Jul 9 8:45 PM | Marshall FordyceDirector, PRESIDENT AND CEO | Sale | 46,250 | $42.30 | $2.0M | 151,994(D) | View → |
| Jun 23, 2026 | Jun 24 8:55 PM | Marshall FordyceDirector, PRESIDENT AND CEO | Sale | 18,500 | $37.93 | $701.8K | 198,244(D) | View → |
| Jun 23, 2026 | Jun 23 8:29 PM | MARSHALL FORDYCE | Proposed Sale | 74,000 | $38.43 | $2.8M | — | View → |
| May 12, 2026 | May 13 8:26 PM | Marshall FordyceDirector, PRESIDENT AND CEO | Sale | 18,500 | $36.74 | $679.7K | 216,744(D) | View → |
| May 12, 2026 | May 12 8:33 PM | MARSHALL FORDYCE | Proposed Sale | 18,500 | $36.61 | $677.3K | — | View → |
| Apr 14, 2026 | Apr 15 8:57 PM | Marshall FordyceDirector, PRESIDENT AND CEO | Sale | 22,951 | $44.05 | $1.0M | 235,244(D) | View → |
| Apr 14, 2026 | Apr 14 8:33 PM | MARSHALL FORDYCE | Proposed Sale | 22,951 | $43.71 | $1.0M | — | View → |
| Feb 23, 2026 | Feb 26 1:01 AM | Robert BrennerChief Medical Officer | Sale | 2,151 | $41.98 | $90.3K | 50,947(D) | View → |
| Feb 23, 2026 | Feb 26 1:00 AM | Joseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR | Sale | 3,117 | $41.98 | $130.9K | 64,722(D) | View → |
| Feb 23, 2026 | Feb 26 12:59 AM | Sean GrantCHIEF FINANCIAL OFFICER | Sale | 4,949 | $41.98 | $207.8K | 114,181(D) | View → |
| Feb 23, 2026 | Feb 26 12:58 AM | Marshall FordyceDirector, PRESIDENT AND CEO | Sale | 16,925 | $41.98 | $710.6K | 257,163(D) | View → |
| Feb 23, 2026 | Feb 26 12:57 AM | David Lee JohnsonChief Operating Officer | Sale | 2,579 | $41.98 | $108.3K | 45,727(D) | View → |
| Feb 23, 2026 | Feb 26 12:56 AM | William D. TurnerChief Regulatory Officer | Sale | 2,187 | $41.98 | $91.8K | 45,313(D) | View → |
| Feb 23, 2026 | Feb 26 12:53 AM | Laurence Matthew SkeltonChief Commercial Officer | Sale | 1,582 | $41.98 | $66.4K | 64,218(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Feb 7 1:00 AM | Sean GrantCHIEF FINANCIAL OFFICER | Grant/Award | 50,000 | $42.74 | 50,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | Laurence Matthew SkeltonChief Commercial Officer | Grant/Award | 40,000 | $42.74 | 40,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | William D. TurnerChief Regulatory Officer | Grant/Award | 50,000 | $42.74 | 50,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | David Lee JohnsonChief Operating Officer | Grant/Award | 40,000 | $42.74 | 40,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | Robert BrennerChief Medical Officer | Grant/Award | 50,000 | $42.74 | 50,000(D) | View → |
← Previous
Page 2 of 2